Hwang, Ahyeon
Skarica, Mario https://orcid.org/0000-0002-2478-014X
Xu, Siwei https://orcid.org/0000-0002-2828-3706
Coudriet, Jensine
Lee, Che Yu https://orcid.org/0000-0002-3039-4894
Lin, Lin https://orcid.org/0000-0002-9640-0687
Terwilliger, Rosemarie
Sliby, Alexa-Nicole
Wang, Jiawei https://orcid.org/0000-0003-2627-4897
Nguyen, Tuan https://orcid.org/0000-0002-1703-0404
Li, Hongyu https://orcid.org/0000-0001-6525-9310
Wu, Min
Dai, Yi https://orcid.org/0009-0004-1018-5931
Duan, Ziheng https://orcid.org/0000-0003-4696-0042
Srinivasan, Shushrruth Sai
Zhang, Xiangyu
Lin, Yingxin https://orcid.org/0000-0002-4299-7326
Cruz, Dianne
Deans, P. J. Michael
,
Alvarez, Victor E.
Benedek, David
Che, Alicia
Cruz, Dianne A.
Davis, David A.
Hoffman, Ellen
Kaye, Alfred
Labadorf, Adam T.
Keane, Terence M.
Logue, Mark W.
McKee, Ann
Marx, Brian
Miller, Mark W.
Noller, Crystal
Montalvo-Ortiz, Janitza
Pierce, Meghan
Scott, William K.
Schnurr, Paula
DiSano, Krista
Stein, Thor
Ursano, Robert
Wolf, Erika J.
Huber, Bertrand R.
Levey, Daniel https://orcid.org/0000-0001-8431-9569
Glausier, Jill R. https://orcid.org/0000-0001-9838-3414
Lewis, David A. https://orcid.org/0000-0002-3225-6778
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
Holtzheimer, Paul E.
Friedman, Matthew J. https://orcid.org/0000-0002-0497-6890
Gerstein, Mark
Sestan, Nenad https://orcid.org/0000-0003-0966-9619
Brennand, Kristen J. https://orcid.org/0000-0003-0993-5956
Xu, Ke https://orcid.org/0000-0002-6472-7052
Zhao, Hongyu https://orcid.org/0000-0003-1195-9607
Krystal, John H. https://orcid.org/0000-0001-6952-1726
Young, Keith A. https://orcid.org/0000-0001-6060-3573
Williamson, Douglas E.
Che, Alicia https://orcid.org/0000-0002-7530-8531
Zhang, Jing https://orcid.org/0000-0002-5970-0509
Girgenti, Matthew J. https://orcid.org/0000-0003-1647-326X
Article History
Received: 3 January 2024
Accepted: 29 April 2025
First Online: 18 June 2025
Competing interests
: J.H.K. has consulting agreements (less than US$10,000 per year) with Aptinyx, Biogen, Idec, MA, Bionomics, Boehringer Ingelheim International, Epiodyne, EpiVario, Janssen Research and Development, Jazz Pharmaceuticals, Otsuka America Pharmaceutical, Spring Care, Sunovion Pharmaceuticals; is the co-founder for Freedom Biosciences; serves on the scientific advisory boards of Biohaven Pharmaceuticals, BioXcel Therapeutics (Clinical Advisory Board), Cerevel Therapeutics, Delix Therapeutics, Eisai, EpiVario, Jazz Pharmaceuticals, Neumora Therapeutics, Neurocrine Biosciences, Novartis Pharmaceuticals Corporation, PsychoGenics, Takeda Pharmaceuticals, Tempero Bio, Terran Biosciences; has stock options with Biohaven Pharmaceuticals Medical Sciences, Cartego Therapeutics, Damona Pharmaceuticals, Delix Therapeutics, EpiVario, Neumora Therapeutics, Rest Therapeutics, Tempero Bio, Terran Biosciences, Tetricus; and is an editor of Biological Psychiatry with income greater than US$10,000. The other authors declare no competing interests.